Advertisement
Home 2016 September

Monthly Archives: September 2016

Diabetes is more widespread among descendants of Canada's First Nations people than among the general population

Diabetes Risk Higher in Canada’s First Nations People

0
Eight of 10 will develop diabetes, and decades sooner than others
Hospitals are increasingly switching to an employment relationship with physicians

Hospitals Increasingly Employing Doctors, Effects on Care Uncertain

0
Switch to employment model not linked to improvement in any of four composite quality metrics
An intervention based on art therapy and clown visits can reduce children's anxiety at preoperative separation from parents

Art Therapy, Clown Visits Cut Children’s Preoperative Anxiety

0
Intervention based on art therapy and clown visits can reduce pre-op anxiety at separation from parents
For patients with critical limb ischemia

Diabetes Ups Risk of Amputation in Critical Limb Ischemia

0
Unadjusted hazard ratio of diabetes mellitus 1.87 for major amputation risk in critical limb ischemia
For women in the third stage of labor

Misoprostol Doesn’t Cut Risk of Postpartum Hemorrhage

0
Misoprostol administered immediately after delivery also linked to more maternal adverse events
Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus

Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

0
Greater change in HbA1c from baseline to 24 weeks with combination therapy versus monotherapies
Following U.S. Preventive Services Task Force recommendations against routine prostate-specific antigen (PSA) screening

Drop in Use of Digital Rectal Examination, PSA Testing

0
Decreases in use of screening following USPSTF recommendations against routine PSA screening
The ratio of B-type natriuretic peptide to upper limit of normal for age

BNPratio Predicts Mortality in Degenerative Mitral Regurgitation

0
Predictor of long-term mortality for patients with MR under medical management
Exondys 51 (eteplirsen) injection has been approved by the U.S. Food and Drug Administration for certain patients with Duchenne muscular dystrophy. It is the first drug to gain FDA approval for the condition.

FDA Approves First Drug for Duchenne Muscular Dystrophy

0
Exondys 51 sanctioned for patients with mutation of the dystrophin gene amenable to exon 51 skipping
Codeine is unsafe for children and should no longer be given to them

AAP Says Codeine Not Safe for Children, Urges Restrictions

0
Doctors should avoid giving drug to children undergoing tonsillectomy, adenoidectomy